Stock News - Context Therapeutics Inc. $CNTX
Latest Stock News for $CNTX
Context Therapeutics Receives FDA Fast Track Designation for CTIM-76 in Ovarian Cancer Treatment
Expected Stock impact: Very Positive
2026-04-02 11:42:28
Context Therapeutics Inc. Updates Corporate Presentation for Investor Meetings
Expected Stock impact: None Expected
2026-03-23 20:24:22
Context Therapeutics Inc. Amends Bylaws Following Court Approval of Stipulated Judgment
Expected Stock impact: Slightly Negative
2026-03-13 20:11:13
